Lead Independent Director · Alto Neuroscience, Inc. (ANRO)

Chair, Compensation Committee

Christopher Nixon Cox — Alto Neuroscience Director Compensation (2025)

Fiscal year 2025 director compensation for Christopher Nixon Cox at Alto Neuroscience, Inc.. Every figure below is printed as the company filed it and cited to the filing it came from.

Director compensation as of the proxy filed March 26, 2026 (DEF 14A). Open the filing on EDGAR.

What they were paid

Alto Neuroscience Director Compensation Table · the one fiscal year held
In US dollars, as Alto Neuroscience reports it. Most recent year first. Totals are the company’s disclosed totals.
Fiscal yearCash feesStock awardsOption awardsOtherTotal
FY2025$4,390—$106,153—$110,543

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Alto Neuroscience, Inc. DEF 14A filed March 26, 2026, accession 0001104659-26-035180, and prior-year filings. Open the filing on EDGAR.

How this board is paid

company policy · FY2025

Alto Neuroscience pays directors a $40,000 cash retainer.

Committees

FY2025 · as the proxy prints them

Audit · Compensation (Chair) · Nominating/Governance

The rest of the Alto Neuroscience board

FY2025 · as the company reported each
DirectorRoleFY2025 total
Amit Etkin, M.D., Ph.DDirector$0
Andrew DreyfusIndependent Director$80,263
Gwill YorkIndependent Director$88,178
Husseini Manji, M.DIndependent Director$73,129
Raymond Sanchez, M.DIndependent Director$84,904

The full Alto Neuroscience compensation record

free company brief

This page is one director within Alto Neuroscience's record. The company brief lists every named executive and director, each linking to their own page.

Velarion Pro: every company page, peer tools and exports, one seat

One email to you when Pro opens, and nothing else. Privacy